Glaukos' iDose TR meets primary goal in phase 4 trial
Glaukos’ iDose TR Phase 4 data shows greater IOP reduction with cataract surgery vs. surgery alone. Read more here.
Market News
What the wires are covering — grouped by story, scored for tone
Previous-day view · Fri Oct 9 close.
You are previewing the previous trading day. Subscribe to see today live and every other
date — plans start at Delta, $39/mo.
Sign up
Sign in
Reading Oct 9's tape
Oct 9
Oct 9
969 storiesToday reads warmer than 1 of the last 2 scored days. Click a bar to read that day's stories.